TRYbeCA-1: A randomized, phase III study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441).

Hammel, P; Berardi, R; Creemers, GY; Cubillo, A; Van Cutsem, E; Greil, R; Macarulla, T; Metges, JP; Noel, MS; Nygren, P; Osterlund, PJ; Seufferlein, T; Wasan, HS; Gupta, A; Grummer, LM; Biswas-Baldwin, N; Kay, R; Youssoufian, H; El-Hariry, I; Hidalgo, M

View this publication in the PUBMED database